How many Belgians have already been vaccinated?
This is the most important table to keep an eye on. Here you first see the number of partially and fully vaccinated people, and also the proportion of vaccinated people compared to the total population.
The higher the percentage of vaccinees, the less chance the virus has to rage. At a vaccination rate of at least 70 percent (of the entire population), there is national group immunity and the virus barely has the chance to spread. We may only achieve group immunity at an even higher percentage.
The figures come from VACCINET and are communicated daily by Sciensano. In reality, the number of vaccinations will be higher, because there is some delay of at least one day on the registration. As soon as Sciensano updates the figures, they are also automatically adjusted here.
Below we show the evolution of all parameters. The proportion of partially and fully vaccinated persons in percentages over time, broken down by region:
Has the population been vaccinated in a balanced way?
Risk groups and the older population are the first to act. You can see that clearly in these tables. Here we indicate what percentage of a certain age group is partially and fully vaccinated.
For the time being, many more women than men have been vaccinated. The cause is twofold: there are statistically more older women than men of the same age, and the proportion of women in the health care workers is higher than the proportion of men.
How many vaccines are administered daily?
How many vaccines (both first and second dose) does our country administer every day? You can see that on this graph. Note: the curve will bend for the last days because the reporting is slow. As soon as new figures are released, this curve will be updated.
How many vaccines do we stock?
Not all doses delivered are administered immediately, the freezers of the hospitals where the vaccines are stored are quite full. That has a reason. In order to be able to vaccinate the priority target group quickly, a reserved portion must be kept in stock, the reasoning goes.
Due to the delay in registration, the surplus will in reality be slightly lower, but we show the latest available data below.
The red dotted line on the graph shows the theoretical stock at the moment. In reality, this is probably lower because the registration of the vaccinations is passed on more slowly.
How many people have already been vaccinated in your municipality?
On this card you can check how many people have already been vaccinated in your municipality. Please note: those who are fully vaccinated are no longer counted with the partially vaccinated. Therefore, the percentage of partially vaccinated may be lower than the percentage of fully vaccinated.
Do you want to know how many people at least received a first dose? Then add the two numbers of the municipality.
In this table you can look up your own municipality:
How is the campaign going in other countries?
How is Belgium doing compared to abroad? You can see this at a glance on the world map and in the table below. Please note, the percentage here is calculated on the entire population, in order to be able to compare correctly with other countries. Reporting can also lag behind.
The comparison when we only look at Europe:
When is it your turn?
Because it is logistically impossible to vaccinate everyone at the same time, the Flemish government has drawn up a vaccination strategy. It will run in phases and will take several months. The entire population is divided into different groups, which are vaccinated at different times. When is it your turn to get a vaccine? Find out using the questions in this test.
View the full strategy in the table below:
Where will you be vaccinated?
Vaccinations are carried out in large locations such as Flanders Expo in Ghent, the Mechelse Nekkerhal and the Heysel Palace in Brussels. But people will also be able to get their corona vaccine in local party halls, sports halls, old hospitals and military buildings.
Here you will find the complete overview of all vaccination sites:
Which vaccines does our country administer?
Belgium has placed orders with five pharmaceutical manufacturers through the European purchasing program. At the moment there are two vaccines that have been approved by the European Union and are in abundance in our country. But what exactly did Europe bring in?
Pfizer-BioNTech
The American pharmaceutical giant Pfizer, with a branch in Puurs, has developed an (RNA) vaccine against the corona virus in collaboration with BioNTech. The clinical trials, involving 40,000 volunteers, show that the vaccine is 95 percent effective.
5 million doses have already been purchased by Belgium, good for the vaccination of 2.5 million people as this vaccine has to be administered twice.
The vaccine is stored at a temperature of -80 degrees.
Modern
The American biotechnology company Moderna developed the RNA vaccine mRNA-1273 against the corona virus. The vaccine appears to be 94.1 percent effective.
Our country bought 2 million doses. The Moderna vaccine should also be vaccinated twice.
The vaccine is stored at a temperature of -20 degrees.
Vaccines have also been ordered from AstraZeneca-Oxford, CureVac and Janssen.
AstraZeneca-Oxford
The (vector) vaccine – AZD1222 (aka ChAdOx1) is a product of the British-Swedish pharmaceutical giant AstraZeneca, which collaborates with Oxford University
The EU has already reserved 400 million doses with AstraZeneca. Of these, 7.5 million are destined for Belgium. Because a double dose is required, this could help 3.75 million fellow countrymen.
The vaccine was approved on January 29 by the European Medicines Agency (EMA) and the European Commission.
The vaccine can be stored for up to six months at a temperature of 2 to 8 degrees and is a lot cheaper than the RNA vaccines from Pfizer and Moderna.
Johnson & Johnson
The Janssen vaccine, like that of AstraZeneca, is a vector vaccine. The difference is that a human cold virus is used in place of a chimpanzee cold virus. Furthermore, the vaccine works like the others. A piece of Covid DNA is built into the vector, which is converted in the body into RNA and protein.
The European Union has agreements with Johnson & Johnson to purchase 200 million doses, with an option for an additional 200 million. Belgium has reserved 5.2 million doses.
The Johnson & Johnson vaccine offers sufficient protection after just one shot. However, it is still being examined whether a second injection at a later time – for example after 6 months or a year – could be interesting for long-term protection.
Johnson & Johnson’s agent can be kept for three months at refrigerator temperature (2 to 8 degrees).
–
